Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53. (Q35737352)

10 August 2017

title

Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53. (English)

1 reference

10 August 2017

13

Vessela Kristensen

0 references

Anne-Lise Børresen-Dale

12

object named as

Anne-Lise Børresen-Dale

1 reference

Hans Kristian Moen Vollan

10 August 2017

5

object named as

Hans Kristian Moen Vollan

1 reference

10 August 2017

2

Laxmi Silwal-Pandit

1 reference

10 August 2017

9

Suet-Feung Chin

1 reference

10 August 2017

8

Olga Troyanskaya

1 reference

10 August 2017

Charles Vaske

6

0 references

Anita Langerød

4

object named as

Anita Langerød

1 reference

10 August 2017

10

Carlos Caldas

1 reference

10 August 2017

3

Ruth Dannenfelser

1 reference

10 August 2017

7

Josie Ursini Siegel

1 reference

10 August 2017

David Quigley

1

1 reference

10 August 2017

Allan Balmain

11

1 reference

10 August 2017

publication date

28 October 2014

1 reference

Molecular Cancer Research

10 August 2017

published in

1 reference

10 August 2017

volume

13

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

493-501

1 reference

TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Defining cell-type specificity at the transcriptional level in human disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Adoptive immunotherapy for cancer: harnessing the T cell response

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Allele-specific copy number analysis of tumors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

When mutants gain new powers: news from the mutant p53 field.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Blinded by the Light: The Growing Complexity of p53

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Tumour immunity: effector response to tumour and role of the microenvironment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Cancer immunoediting: from immunosurveillance to tumor escape

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Molecular portraits of human breast tumours

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465579

Granzyme B-induced cell death involves induction of p53 tumor suppressor gene and its activation in tumor target cells

15 November 2018

1 reference

12 December 2020

The humoral immune system has a key prognostic impact in node-negative breast cancer

1 reference

12 December 2020

Skin cancer and immunosuppression

1 reference

12 December 2020

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

12 December 2020

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens

1 reference

12 December 2020

10.1158/1541-7786.MCR-14-0387

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference